Market Overview:
The global Lancet and Lancing Devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about self-monitoring of blood glucose levels, and technological advancements in lancing devices. The safety lancets segment is expected to dominate the global Lancet and Lancing Devices market during the forecast period owing to their advantages such as less pain and easy disposal. The homecare lancets segment is projected to grow at a higher CAGR than other segments during the forecast period due its low cost and easy availability. By application, the cholesterol tests segment is expected to account for a major share of the global Lancet and Lancing Devices market during 2018-2030 owingtoits high prevalence across all regions studied in this research study.
Product Definition:
Lancet: a small, pointed tool used for making incisions, especially in medical procedures.
Lancing Devices: a medical device that is used to prick the skin in order to obtain blood or other fluid specimens.
Safety Lancets:
Safety lancets are used in blood glucose testing. They are also known as drawing sticks or safety pins, and they have a small spike on one end. The spike is used to puncture the skin and allow access to the underlying vein for drawing blood sample.
Easy To Use - They should be easy to handle so that they can fit easily in hand of patient without any assistance from patient itself.
Homecare Lancets:
Homecare lancets and it's usage in Lancet and Lancing Devices market is a new term which entered the medical industry recently. It is still not well known among consumers as well as healthcare providers. However, with growing awareness about home-based services for basic patient care, this service will gain more popularity over the forecast period. Homecare lancets are used in drawing blood from patients at home or any other place where there is no access to an outpatient clinic or hospital laboratory.
Application Insights:
Based on the application, the global market has been segmented into cholesterol tests, glucose tests, other test panels. The cholesterol tests segment dominated the overall market in terms of revenue share in 2017. This is due to an increase in demand for lancing devices and other blood testing equipment as a result of growing awareness about preventive healthcare and rising incidences of lifestyle disorders such as heart diseases along with them. According to WHO's Global Health Observatory (GHO), around 1 billion people have cardiovascular diseases (CVDs) globally which amounts to around 30% of all deaths caused by disease worldwide.
The glucose tolerance test is expected to be the fastest-growing application owing to its increasing adoption among individuals suffering from diabetes mellitus type 2 or at risk thereof coupled with a rise in demand for self-monitoring devices used during this procedure that measures one's blood sugar levels before and after meals consumed thereby enabling effective management associated with these conditions.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high awareness levels about blood glucose testing, and availability of advanced products. The region is expected to maintain its position during the forecast period owing to factors such as increasing prevalence of diabetes and cholesterol disorders among people coupled with growing geriatric population prone to infections.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as improving healthcare infrastructure, rising disposable income level, and a large target population base within this region. Moreover, an increase in cases of infectious diseases like Ebola virus disease (EVD) has led governments across countries in this region including India & China & Singapore etc.
Growth Factors:
- Increasing incidence of diabetes and other chronic diseases: The global prevalence of diabetes is expected to increase from 9% in 2013 to 11% by 2030. This will create a large pool of patients who will require regular blood glucose monitoring and treatment, thereby driving the demand for lancing devices.
- Technological advancements: The development of new lancing devices with features such as adjustable depth, vibration feedback, and pre-set depths is likely to boost the growth of the Lancet and Lancing Devices market.
- Rising awareness about self-monitoring: There is a growing awareness among people about the importance of self-monitoring blood glucose levels in order to maintain good glycemic control. This is likely to drive demand for lancing devices in the coming years.
- Growing geriatric population: The global geriatric population (aged 65 years or above) is projected to reach 1 billion by 2050, creating a large pool of patients susceptible to various chronic diseases including diabetes mellitus type 2 (DM2). This will spur demand for lancet needles and other related products used for diagnostics and treatment purposes across the globe . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Lancet and Lancing Devices Market Research Report
By Type
Safety Lancets, Homecare Lancets
By Application
Cholesterol Tests, Glucose Tests, Other
By Companies
Roche, Lifescan, BD, Panasonic (Bayer), Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Omron, Infopia, AgaMatrix, Smiths Medical, Sarstedt, SANNUO, Yicheng, Yuwell, Greiner Bio One, Edan, Narang Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Lancet and Lancing Devices Market Report Segments:
The global Lancet and Lancing Devices market is segmented on the basis of:
Types
Safety Lancets, Homecare Lancets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cholesterol Tests, Glucose Tests, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Lifescan
- BD
- Panasonic (Bayer)
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Omron
- Infopia
- AgaMatrix
- Smiths Medical
- Sarstedt
- SANNUO
- Yicheng
- Yuwell
- Greiner Bio One
- Edan
- Narang Medical
Highlights of The Lancet and Lancing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Safety Lancets
- Homecare Lancets
- By Application:
- Cholesterol Tests
- Glucose Tests
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lancet and Lancing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lancet is a medical journal published by The Lancet Trust. It was founded in 1823 and is the world's oldest continuously publishing medical journal. A lancing device, also known as a lancet, is an instrument used to puncture the skin for diagnostic or therapeutic purposes.
Some of the major companies in the lancet and lancing devices market are Roche, Lifescan, BD, Panasonic (Bayer), Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Omron, Infopia, AgaMatrix, Smiths Medical, Sarstedt, SANNUO, Yicheng, Yuwell, Greiner Bio One, Edan, Narang Medical.
The lancet and lancing devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lancet and Lancing Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lancet and Lancing Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lancet and Lancing Devices Market - Supply Chain
4.5. Global Lancet and Lancing Devices Market Forecast
4.5.1. Lancet and Lancing Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lancet and Lancing Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lancet and Lancing Devices Market Absolute $ Opportunity
5. Global Lancet and Lancing Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lancet and Lancing Devices Market Size and Volume Forecast by Type
5.3.1. Safety Lancets
5.3.2. Homecare Lancets
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lancet and Lancing Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lancet and Lancing Devices Market Size and Volume Forecast by Application
6.3.1. Cholesterol Tests
6.3.2. Glucose Tests
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lancet and Lancing Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lancet and Lancing Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lancet and Lancing Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lancet and Lancing Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lancet and Lancing Devices Demand Share Forecast, 2019-2029
9. North America Lancet and Lancing Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lancet and Lancing Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lancet and Lancing Devices Market Size and Volume Forecast by Application
9.4.1. Cholesterol Tests
9.4.2. Glucose Tests
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lancet and Lancing Devices Market Size and Volume Forecast by Type
9.7.1. Safety Lancets
9.7.2. Homecare Lancets
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lancet and Lancing Devices Demand Share Forecast, 2019-2029
10. Latin America Lancet and Lancing Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lancet and Lancing Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lancet and Lancing Devices Market Size and Volume Forecast by Application
10.4.1. Cholesterol Tests
10.4.2. Glucose Tests
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lancet and Lancing Devices Market Size and Volume Forecast by Type
10.7.1. Safety Lancets
10.7.2. Homecare Lancets
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lancet and Lancing Devices Demand Share Forecast, 2019-2029
11. Europe Lancet and Lancing Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lancet and Lancing Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lancet and Lancing Devices Market Size and Volume Forecast by Application
11.4.1. Cholesterol Tests
11.4.2. Glucose Tests
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lancet and Lancing Devices Market Size and Volume Forecast by Type
11.7.1. Safety Lancets
11.7.2. Homecare Lancets
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lancet and Lancing Devices Demand Share, 2019-2029
12. Asia Pacific Lancet and Lancing Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lancet and Lancing Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lancet and Lancing Devices Market Size and Volume Forecast by Application
12.4.1. Cholesterol Tests
12.4.2. Glucose Tests
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lancet and Lancing Devices Market Size and Volume Forecast by Type
12.7.1. Safety Lancets
12.7.2. Homecare Lancets
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lancet and Lancing Devices Demand Share, 2019-2029
13. Middle East & Africa Lancet and Lancing Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lancet and Lancing Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lancet and Lancing Devices Market Size and Volume Forecast by Application
13.4.1. Cholesterol Tests
13.4.2. Glucose Tests
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lancet and Lancing Devices Market Size and Volume Forecast by Type
13.7.1. Safety Lancets
13.7.2. Homecare Lancets
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lancet and Lancing Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Lancet and Lancing Devices Market: Market Share Analysis
14.2. Lancet and Lancing Devices Distributors and Customers
14.3. Lancet and Lancing Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Lifescan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Panasonic (Bayer)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. B. Braun
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ARKRAY
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Terumo
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. I-SENS
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nipro
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Omron
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Infopia
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. AgaMatrix
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Smiths Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Sarstedt
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. SANNUO
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Yicheng
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Yuwell
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Greiner Bio One
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Edan
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
